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Natural molecules are under intensive study for their potential as preventive and/or adjuvant therapies for neurodegenerative
disorders such as Parkinson’s disease (PD). We evaluated the neuroprotective potential of cucurbitacin E (CuE), a tetracyclic
triterpenoid phytosterol extracted from the Ecballium elaterium (Cucurbitaceae), using a known cellular model of PD, NGF-
differentiated PC12. In our postmitotic experimental paradigm, neuronal cells were treated with the parkinsonian toxin 1-methyl-
4-phenylpyridinium (MPP+) to provoke significant cellular damage and apoptosis or with the potent N,N-diethyldithiocarbamate
(DDC) to induce superoxide (O
2
∙−) production, and CuE was administered prior to and during the neurotoxic treatment. We
measured cellular death and reactive oxygen species to evaluate the antioxidant and antiapoptotic properties of CuE. In addition,
we analyzed cellular macroautophagy, a bulk degradation process involving the lysosomal pathway. CuE showed neuroprotective
effects on MPP+-induced cell death. However, CuE failed to rescue neuronal cells from oxidative stress induced by MPP+ or DDC.
Microscopy and western blot data show an intriguing involvement of CuE in maintaining lysosomal distribution and decreasing
autophagy flux. Altogether, these data indicate that CuE decreases neuronal death and autophagic flux in a postmitotic cellular
model of PD.
1. Introduction
Mitochondrial dysfunction has been recently recognized to
contribute to the onset of many neurodegenerative diseases
characterized by protein aggregation, cellular inclusions,
impairment of metabolic functions, and cellular trafficking
[1–3]. In Parkinson’s disease (PD), for example, these effects
lead to the degeneration of the nigrostriatal dopaminergic
(DAergic) pathway characterized by the selective death of
DAergic neurons and dopamine content depletion [4]. The
hypotheses regarding the etiology of PD pinpoint mitochon-
drial defects and oxidative stress, ranging from mutations
in proteins regulating mitochondrial turnover to functional
impairment of the respiratory chain, as major causes of neu-
rodegeneration [5, 6]. Moreover, formation of the character-
istic protein inclusions of PD, Lewy bodies, illustrates the
challenge of protein misfolding and aggregation, not rescued
by cellular degradation mechanisms [7].
The autophagy-lysosomal degradation pathway, which
is essential for turnover of mitochondria (mitophagy) and
degradation of aggregated proteins (aggrephagy), has been
linked with the development of neurodegenerative disorders
[8–11]. Its impairment leads to formation of protein inclu-
sions and accumulation of damaged mitochondria, a major
source of reactive oxygen species (ROS) [12, 13]. ROS can
then oxidize proteins, eventually inducing their misfolding
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Figure 1: (a) Immunofluorescence picture revealing the neuronal phenotype of PC12 cells after 5 days of NGF treatment. TH: tyrosine
hydroxylase, as marker of dopamine; NFL: neurofilament-low-chain, as a marker of neuronal cytoskeleton. Nuclei were counterstained with
DAPI. (b) Experimental set-up. CuE 10−10M was administered 3 hours before MPP+ or DDC or bafilomycin (Baf) or rapamycin (Rap)
treatment. CuE was administered once more 15min after MPP+ or DDC or Baf or Rap.
and aggregation, and trigger the apoptotic cascade. Protein
inclusions and accumulation of damaged mitochondria have
been observed for decades in the brains of PD patients [4,
14]. Impaired autophagy has also been observed in animal
models of PD and in human postmortem brain sections
[15, 16]. Mutations in genes associated with familial PD, such
as parkin, PINK1, LRRK2, and DJ-1, impair mitochondrial
turnover and protein aggregate clearance [17–20]. Hence, the
accumulation of protein aggregates and toxic mitochondria
in the cytoplasm may prompt increased oxidative stress and,
over time, cell death.
Impairment of the respiratory chain complex I found in
PD brains [21, 22] is reproduced by treatment with 1-methyl-
4-phenylpyridinium (MPP+), the active metabolite of 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neu-
rotoxin which causes a Parkinson-like syndrome in many
model organisms and in humans [23–25]. MPP+ crosses the
blood-brain barrier and is converted into toxic MPP+ in
astrocytes by the enzyme monoamine oxidase B [4]. It is
then incorporated by dopaminergic (DAergic) neurons via
the dopamine transporter (DAT) and interferes directly with
complex I of the respiratory chain in the mitochondrion
[26, 27], leading to production of ROS, oxidative stress, and
apoptosis.
In the last decade, a growing number of studies have re-
vealed several natural molecules possessing interesting anti-
oxidant and antiapoptotic properties in neuronal cell cul-
ture and in animal models of neurodegeneration that may
improve cognitive health in humans [23, 28–35]. Among
them, cucurbitacins, triterpene steroids extracted mainly
from the Cucurbitaceae plant family, have been studied for
their antitumoral, anti-inflammatory, and antioxidant prop-
erties [36–40]. In particular, cucurbitacin E (CuE) has been
reported to possess anti-inflammatory and antiproliferative
properties [41], effectsmediated by its action on the polymeri-
sation of the actin cytoskeleton [42–45].
The aim of this work was to evaluate CuE as a preventive
treatment for the onset of neuronal death induced by the
potent parkinsonian toxin MPP+ in a neuronal DAergic
model. We first assessed CuE against MPP+-induced cellular
death.Then, we examined the antioxidant properties of CuE,
and finally we investigated the autophagic degradation path-
way as a potential mechanism for CuE-mediated neuropro-
tection. The modulation of autophagy by CuE suggests that
this could contribute to its neuroprotective effect of CuE. To
our knowledge this is the first time that CuE is used in a
postmitotic neuronal model and shows neuroprotective and
autophagy regulating properties.
2. Materials and Methods
2.1. Drugs and Chemicals. All reagents and chemicals were
purchased from Sigma (St. Louis, MO) unless stated other-
wise.
2.2. Cucurbitacin E Extraction and Purification. CuE was
extracted from the fruit juice of Ecballium elaterium (L.)
A.Rich., collected from Marsascala (Malta) with a yield of
52% from the prepared elaterin. Briefly, the fruit juice was
dried at 40∘C and extracted with CHCl
3
(5mL) and then
mixed with an equal volume of petroleum ether. The filtrate
was dissolved in absolute EtOH and then filtered through a
0.22𝜇m pore size membrane. The purity of the compound
(98.24%) was analysed by spectroscopy and HPLC [46].
2.3. Cell Culture and Treatments. PC12 cells, obtained from
the American Type Culture Collection (Rockville, MD), were
maintained in a humidified environment at 37∘C and 5%
CO
2
atmosphere. They were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) heat-
inactivated horse serum (HS), 5% (v/v) heat-inactivated fetal
bovine serum (FBS), and gentamicin (50 𝜇g/mL). Neuronal
PC12 cell differentiation was evoked by nerve growth factor-
7S (NGF, 50 ng/mL) inDMEMsupplementedwith 1%FBS for
5 days (Figure 1(a)), as already described in [28, 47]. In these
conditions, 85% of na¨ıve PC12 differentiated into neuronal
cells. Treatments with CuE and MPP+ were performed in
DMEM medium without phenol red supplemented with 1%
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Figure 2: Dose-response studies. Cells were pretreated with CuE
concentrations ranging from 10−6 to 10−10M for 3 h and then
exposed to 5mM MPP+. Cytotoxicity was measured using the col-
orimetric LDH release assay. The absorbance value obtained for the
untreated control was subtracted from all other values, as described
in Materials and Methods. Administration of CuE alone induced
minimal cellular death. Values are the average of 6 samples from 4
independent experiments for a total of 24 measurements. Data are
expressed as means ± S.E.M. 𝑛 = 4. ◊◊◊𝑃 < 0.001 versus MPP+.
charcoal-stripped FBS. Cells were pretreated with CuE
10−10M for 3 h and then exposed to 5mM or 500𝜇M MPP+
for 24 h [48]. CuE 10−10M was added once more for 15min
after MPP+ administration, as illustrated in Figure 1(b). Neu-
roprotective CuE concentration was determined by dose-
response experiments (Figure 2). Administration of CuE
alone induces only minimal cellular death (Figure 3). Bafil-
omycin A
1
(Baf) 100 nM, inhibiting lysosomal acidification,
was used to assess autophagic flux [49, 50]. Rapamycin (Rap)
(500 nM), an inhibitor of mammalian target of rapamycin
(mTOR), was used as an inducer of autophagy [51]. Both
were used separately on live cells 1 hour prior to extraction
or fixation (Figure 1(b)). All experiments were performed
in charcoal-stripped serum to remove steroids from the
medium.
2.4. Cytotoxicity Measurements. Cytotoxicity was evaluated
by a colorimetric assay based on the measurement of super-
natant lactate dehydrogenase (LDH) activity, as already
described in [28]. The amount of enzyme activity detected
in culture supernatant correlates with the portion of lysed
cells [52]. Briefly, 50 𝜇L of cell-free supernatant was harvested
to quantify LDH activity by measuring absorbance at a
wavelength of 490 nm with a microplate reader (Thermolab
Systems, Franklin, MA). Total cellular LDH was determined
by lysing the cells with 1% Triton X-100 (high control); the
assay medium served as the low control and was subtracted
from all absorbance measurements:
Cytotoxicity (%)=
experimental value − low control
high control − low control
× 100.
(1)
2.5. Specific DNA Denaturation Detection. Specific detection
of DNA denaturation was studied using the single-stranded
DNA (ssDNA) apoptosis ELISA kit (Chemicon International,
Billerica, MA), as already reported in [47, 53].This procedure
is based on selective DNA denaturation by formamide and
heat in apoptotic cells that does not occur in necrotic cells
or in cells with DNA breaks in the absence of apoptosis [54].
The detection of denatured DNAwas performed with amon-
oclonal antibody highly specific to ssDNA and a peroxidase-
labelled secondary antibody on fixed neuronal PC12 cells,
seeded at 25 000 cells/cm2 in 96-well plates. The reaction
was then stopped with a hydrochloric acid solution and
ssDNA was quantified by measuring absorbance at 405 nm
in a microplate reader (Thermolab Systems). ssDNA was
analyzed with reference to control conditions. Absorbance
of positive (wells coated with ssDNA) and negative controls
(wells coated with S1 nuclease) served as quality controls for
the ELISA assay, as previously described in [47, 53].
2.6. ROS Detection. The antioxidant effect of CuE against
MPP+-induced ROS production was evaluated by the dihy-
drorhodamine 123 (DHR) assay and MitoSOX Red (Invit-
rogen, Burlington, ON, Canada), according to a previ-
ously described method [55]. Briefly, to detect OH∙, NO
2
∙,
CO
3
∙−, H
2
O
2
, HOCl, and ONOO− by DHR [56, 57], NGF-
differentiated PC12 cells were grown and treated on collagen-
coated circular glass coverslips. Then, they were quickly
washed with PBS 0.1M and exposed to 250𝜇L of DHR
at 37∘C for 20min. Slides with live cells were immediately
examined under a Leitz Orthoplan fluorescence microscope
(Leica, Wetzlar, Germany) and photographed with a QImag-
ing camera (Nikon, Mississauga, ON, Canada), as already
described in [55]. Fluorescence intensity was measured using
NIS Elements 2.2 software (Nikon).
The antioxidant effects of CuE against mitochondrial
superoxide anion (O
2
∙−) production were evaluated with
MitoSOX Red, as already described in [47, 55]. NGF-
differentiated PC12 cells were washed with Hank’s buffered
salt solution (HBSS) and incubated for 10min at 37∘C with a
5 𝜇M solution of MitoSOX Red. Nuclei were counterstained
with Hoechst 33342 (5 𝜇g/mL) for 15min at 37∘C, and then
cells were fixed for 20min in 4% paraformaldehyde at
37∘C, mounted on glass slides with ProLong Antifade kit
(Invitrogen), examined under a Leitz Orthoplan fluorescence
microscope (Leica), and photographed with a QImaging
camera (Nikon). Fluorescence intensity was measured using
NISElements 2.2 software (Nikon). To demonstrateMitoSOX
Red selectivity, a positive control was performed using
sodium diethyldithiocarbamate (DDC), a superoxide dismu-
tase (SOD) inhibitor, in control medium.
2.7. Immunofluorescence. NGF-differentiated PC12 cells were
grown and treated on collagen-coated circular glass cover-
slips in 24-well plates. Cells were fixed for 20min at 37∘C
in 4% paraformaldehyde, then washed, and incubated for 1 h
at room temperature (RT) in a blocking and permeabilizing
solution, as already described in [47, 55].
For lysosomes and mitochondria detection, coverslips
were incubated overnight with lysosome-associated mem-
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Figure 3: (a) Effects of CuE on cytotoxicity induced by MPP+ in neuronal PC12 cells, as measured by colorimetric LDH release assay. The
absorbance value obtained for the untreated control was subtracted from all other values, as described in Materials and Methods. MPP+
treatment shows an important enhancement of cellular death, compared to control condition. Administration of CuE powerfully rescues
MPP+-induced cellular death. Values are the average of 6 samples from 4 independent experiments for a total of 24 measurements. Data
are expressed as means ± S.E.M. 𝑛 = 4. ∗∗∗𝑃 < 0.001 versus Ctrl and ◊◊𝑃 < 0.01 versus MPP+. (b) Detection of DNA denaturation using
monoclonal antibodies against single-stranded DNA. Neuronal PC12 cells treated with MPP+ alone show a significant increase in cell death
compared to control (Ctrl). Administration of CuE prior to MPP+ (CuE +MPP+) shows a decrease in DNA denaturation compared toMPP+
alone. Values are the average of 6 samples from 3 independent experiments for a total of 18 measurements. Data are expressed as means ±
S.E.M. 𝑛 = 4. ∗∗𝑃 < 0.01 versus Ctrl and ◊𝑃 < 0.05 versus MPP+.
brane protein-2a (LAMP2, Novus Biologicals NBP1-95696)
and with mitochondria-specific heat-shock protein-70
(mtHSP70, ABR Bioreagents MA3-28) antibodies, respec-
tively, followed by fluorescent secondary antibodies (Alexa
Fluor 488 and 594, Jackson ImmunoResearch). Slides were
examined under a Zeiss confocal microscope using ZEN
Imaging software (Zeiss, Toronto, ON, Canada).
Immunofluorescence detection of the cellular cytoskele-
ton was performed by exposing fixed cells with anti-actin
1 : 1,000 (Sigma A2066), anti-𝛽3-tubulin 1 : 1,000 (Santa Cruz
Biotechnology sc-80005), and anti-neurofilament-M 1 : 3,000
(NF-M, SigmaN5264) antibodies followed by the appropriate
anti-rabbit fluorescein isothiocyanate (FITC, Sigma F0382)
or anti-mouse Cy3 (Sigma C2181) fluorescent secondary
antibodies and DAPI nuclear staining. Slides were examined
under a Zeiss confocal microscope using ZEN Imaging soft-
ware (Zeiss).
Recently, detecting microtubule-associated protein 1A/
1B-light chain 3 (LC3) has become a reliable method for
monitoring autophagy and autophagy-related processes [58].
The amount of LC3-II is clearly correlated with the number
of autophagosomes [59]. We used immunofluorescence on
cells grown and treated on coverslips. Cells were then exposed
overnight with a primary antibody for LC3b 1 : 250 (Cell Sig-
naling Techn. 3868) at 4∘C.Afterwashingwith PBS, cells were
exposed to the fluorophore-conjugated secondary antibody,
anti-mouseCy3 (InvitrogenA-21467). Finally, coverslipswere
mounted on glass slides with ProLong Antifade kit (Invit-
rogen) and examined under an Olympus Corporation
FV1200S confocal microscope using Fluoview 10-ASW 4.0
software (Olympus, Richmond Hill, ON, Canada). Percent-
age of cell occupied by puncta stained with LC3b (area frac-
tion) was quantified using ImageJ free software (http://imagej
.nih.gov/).
2.8. Analysis of Autophagosomes. The vital dye acridine
orange and the specific autophagy epifluorescent dye Cyto-
ID (Enzo Life Sciences) were used for autophagy detection.
Acridine orange is a lysotropic dye that accumulates in late
acidic autophagic vacuoles [60]. Cyto-ID is dye for autoph-
agosomes [61–63].
NGF-differentiated PC12 cells were seeded at 25 000 cells/
cm2 and acridine orange or Cyto-ID staining was performed
immediately after experimental treatments on live cells,
according to themanufacturer’s instructions. Positive control
for autophagy was rapamycin (500 nM), a known mTOR
inhibitor and autophagy inducer. All coverslips were rinsed
with PBS and nuclei counterstained with Hoechst 33342
(5 𝜇g/mL); then cells were fixed with 4% paraformaldehyde
andmounted on glass slideswith ProLongAntifade kit (Invit-
rogen). Cells were observed with a Leitz Orthoplan micro-
scope (Leica) and photographed with a QImaging camera
(Nikon). Fluorescence intensity was measured by NIS Ele-
ments 2.2 software (Nikon) for acridine orange. Vacuoles
larger than 1 𝜇m stained with Cyto-ID were blindly counted
on 10 different optic fields from at least 3 slides per group [48]
using ImageJ free software (http://imagej.nih.gov/).
2.9. Electrophoresis and Immunoblot Analysis. NGF-differ-
entiated PC12 cells were grown and treated in collagen-coated
6-well plates. Total cellular proteins were extracted using
nuclear extraction kit (Active Motif, Carlsbad, CA, USA).
Cells were lysed and protein concentration was quantified
by BCA protein assay kit (Pierce, Rockford, IL, USA). Equal
amounts of proteins were loaded onto 10% sodium dodecyl
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Figure 4: Rhodamine detection of ROS in neuronal PC12 cells after MPP+ and/or CuE treatment. Nonfluorescent DHR is converted to
fluorescent rhodamine in the presence of several free radicals (OH∙, NO
2
∙, CO
3
∙−, H
2
O
2
, HOCl, and ONOO−). (a) Fluorescent microscopy.
A significant signal is marked in neuronal cells treated with MPP+ but not in those exposed to CuE or the vehicle (Ctrl). Administration of
CuE +MPP+ does not reduce fluorescence significantly compared toMPP+ alone. Scale bar = 10 𝜇m. (b)Histogram. Semiquantitative analysis
of rhodamine fluorescence. Data are expressed as relative fluorescence units and are means ± S.E.M. 𝑛 = 4. ∗∗∗𝑃 < 0.001 versus Ctrl and n.s.
= nonsignificant.
sulphate polyacrylamide gels. After electrophoretic separa-
tion (125V, for 1 h30), proteins were transferred onto PVDF
membranes (0.22𝜇m pore size, BioRad, Mississauga, ON,
Canada) at 25V overnight. The membranes were blocked for
30min to 1 h at RT and incubated overnight at 4∘C with
primary antibodies, anti-p62, a cargo protein, 1 : 1000 (Pro-
gen Biotechnik GmbH, GP62-C), and antityrosine hydrox-
ylase (TH) 1 : 2000. Membranes were then incubated with
horseradish peroxidase-conjugated secondary antibodies
1 : 10,000 for 1 h30 at RT. Immunopositive signals were visual-
ized by enhanced chemiluminescence with the AlphaEaseFC
imaging system (Alpha Innotech, San Leandro, CA, USA)
and analyzed with AlphaEaseFC software (Alpha Innotech)
and ImageJ (http://imagej.nih.gov/). TH is the enzyme
responsible for the conversion of L-tyrosine to L-3,4-dihy-
droxyphenylalanine (L-DOPA) which is the precursor for
dopamine. TH is found ubiquitously in neuronal differenti-
ated PC12 and was used to normalise the p62 signal as in our
6 Oxidative Medicine and Cellular Longevity
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Figure 5: Selective detection of superoxide anion by MitoSOX Red. This fluorogenic dye enters the cell and is oxidized by O
2
∙− to a red
fluorescent molecule. DDC, a specific superoxide dismutase inhibitor, was used as a positive control for O
2
∙− production. (a) Fluorescence
microphotographs show intense MitoSOX Red signal in DDC exposed cells. CuE does not rescue cells from oxidative stress as O
2
− levels are
equally high in DDC condition with or without CuE pretreatment. Untreated control and CuE-only condition show similar low fluorescence
levels. Nuclei were counterstained in blue with Hoechst 33342. Scale bar = 10 𝜇m. (b) Histogram. Semiquantitative measures of MitoSOX Red
fluorescence. Data are expressed as relative fluorescence units and are means ± S.E.M. 𝑛 = 3. ∗∗𝑃 < 0.01 versus Ctrl. n.s. = nonsignificant.
experiments CuE does not modulate TH expressions (data
not shown).
2.10. Statistical Analysis. Significant differences between
groups were ascertained by one-way analysis of variance
(ANOVA), followed by Tukey’s post hoc analysis, achieved
with theGraphPad InStat program, version 3.06 forWindows
(http://www.graphpad.com/). All data, analyzed at the 95%
confidence interval, were expressed asmeans± S.E.M. fromat
least 3 independent experiments. Asterisks indicate statistical
differences between MPP+ and control (∗∗∗𝑃 < 0.001,
∗∗
𝑃 < 0.01, and ∗𝑃 < 0.05) and diamonds denote statistical
differences between the treatment andMPP+ or Baf condition
(◊◊◊𝑃 < 0.001, ◊◊𝑃 < 0.01, and ◊𝑃 < 0.05).
3. Results
3.1. CuE Treatment Reduces MPP+-Induced Cell Death.
The neuroprotective effects of CuE in PC12 neuronal cells
(Figure 1(a)) treated with MPP+ were assessed by measur-
ing LDH release. Experimental CuE concentrations were
determined by a dose-response assay aimed at finding the
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Figure 6: Acridine orange detection of acidic lysosomes. Acridine orange enters acidic compartments such as lysosomes and becomes
protonated and sequestered. (a) Microphotographs illustrating an intense fluorescence when CuE is administered alone and low of
fluorescence in MPP+ or CuE +MPP+ conditions. Nuclei were counterstained in blue with Hoechst 33342. Scale bar = 10 𝜇m. (b) Histogram.
Semiquantitative measures of acridine orange fluorescence. Data are expressed as relative fluorescence units and are means ± S.E.M. 𝑛 = 3.
∗∗∗
𝑃 < 0.001 versus Ctrl.
lowest neuroprotective dose of CuE in neuronal PC12 cells
(Figure 2). After a 24 h treatmentwith 5mMMPP+, cell death
was significantly higher in MPP+-treated cells than in cells
treated with MPP+ and CuE concentrations ranging from
1 𝜇M to 1 pM (Figure 2). Figure 3(a) shows that treatment
with 10−10M CuE reduced MPP+-induced cellular death
(CuE + MPP+) by 70%, while treatment with CuE alone
minimally affected cell death (CuE).
Neuronal death was also detected by a specific DNA
denaturation assay (Figure 3(b)). After a 24 h treatment
with 500𝜇M MPP+, specific apoptotic DNA denaturation
increases by 44% compared to control condition (Ctrl). CuE
administration reduced significantly the amount of DNA
denaturation (CuE + MPP+) while CuE treatment alone
caused no significant changes (Figure 3(b)).
3.2. CuE Does Not Significantly Lower Oxidative Stress. DHR
is oxidized to fluorescent rhodamine by free radicals such
as OH∙, NO
2
∙, CO
3
∙−, H
2
O
2
, HOCl, and ONOO− [56, 57].
Figures 4(a) and 4(b) illustrate that fluorescence levels were
significantly increased after MPP+ treatment compared to
control conditions, supporting the oxidative nature of the
MPP+ neurotoxin [47, 55]. CuE alone did not modulate
rhodamine fluorescence and the administration of CuE with
MPP+ (CuE +MPP+) failed to significantly lower free radical
levels compared to MPP+ alone, in our postmitotic neuronal
paradigm (Figures 4(a) and 4(b)).
To further study the antioxidant potential of CuE, we
used MitoSOX Red to measure its ability to quench ROS
generated by the inhibition of superoxide dismutase (SOD)
(Figures 5(a) and 5(b)). Cells were treated with or without
vehicle, CuE or DDC, a potent SOD inhibitor, for 3 h, as
previously reported in [47, 55]. This time period was chosen
since free radical generation and oxidative stress are early
events in the causative process of cellular death [64, 65]
and experimentally generated the best detectable superoxide
levels [47, 55]. Figures 5(a) and 5(b) show that fluorescence
levels were, as expected, the highest in DDC-treated cells and
that CuE treatment could not revert the superoxide anion
levels induced by the inhibition of SOD (DDC + CuE), thus
suggesting that CuE had no preventive effect on superoxide
anion levels. Control conditions display low levels of red flu-
orescence and CuE treatment alone shows similar low levels.
3.3. CuE Regulates the Presence of Autophagic Vacuoles. Since
CuE acts as a neuroprotective molecule but does not play an
antioxidant role to promote neuronal survival in our post-
mitotic model, we examined whether CuE could modulate
autophagy, a cellular process allowing the degradation and
recycling of cellular components, thus playing an important
role in neuronal survival. We first analysed the effect of CuE
and MPP+ on the presence of acidic vesicles as illustrated by
acridine orange red fluorescence (Figures 6(a) and 6(b)).
Consistent with a depletion of lysosomes by MPP+ [66],
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Figure 7: Epifluorescence analysis of autophagy in neuronal PC12 cells treated with CuE and/or MPP+ using Cyto-ID autophagy detection
kit. (a) Histogram. Total content of vacuoles positive for Cyto-ID. CuE administration could not change the total number of vacuoles while
MPP+ considerably decreases cellular vacuole content. (b) Histogram. Number of vacuoles larger than 1 𝜇m per cell. Administration of CuE
alone clearly induces an increased number of larger than 1 𝜇m vacuoles. Administration of MPP+ intensely reduces the presence of these
large vacuoles. Pretreatment with CuE before MPP+ (CuE + MPP+) still shows similar levels of large vacuoles as in CuE-alone treatment. (c)
Fluorescent microscopy. CuE-treated cells show an increased number of autophagic vacuoles larger than 1 𝜇m (arrowheads). Positive control
for autophagy was rapamycin, a known autophagy inducer. Nuclei were counterstained in blue with Hoechst 33342. Scale bar = 10 𝜇m. Data
are expressed as number of vacuoles larger than 1 𝜇m per cell and are means ± S.E.M. 𝑛 = 3. ∗∗𝑃 < 0.01 and ∗𝑃 < 0.05 versus Ctrl. ◊◊𝑃 < 0.01
versus MPP+ and n.s. = nonsignificant.
Figures 6(a) and 6(b) illustrate a dramatic decrease in acri-
dine orange-positive vesicles when PC12 neuronal cells were
exposed to MPP+. In contrast, CuE caused an accumulation
of acidic vesicles, although it did not rescue acridine orange
staining in MPP+-treated cells (CuE + MPP+). This suggests
that CuE may act on the autophagy-lysosomal pathway.
We then analysed the presence of autophagic vacuoles
using Cyto-ID, a green fluorescent dye that accumulates in
autophagic vacuoles but not lysosomes [61–63] (Figures 7(a)
and 7(b)). Although CuE treatment did not alter the overall
number of Cyto-ID-positive vacuoles (Figure 7(a)), it pro-
voked the accumulation of large (>1𝜇m) vacuoles in neuronal
PC12 cells (Figure 7(b)). In addition and in contrast to the
staining of acidic vacuoles with acridine orange shown in
Figure 6, CuE prompted the accumulation of large Cyto-
ID-positive vacuoles (>1 𝜇m) even in the presence of MPP+
(CuE + MPP+), suggesting that CuE may regulate autophagy
upstreamof lysosomes. Rapamycin, a known inducer of auto-
phagy, was used as positive control for Cyto-ID staining.
Altogether, these results suggest that CuE regulates the
autophagolysosomal pathway.
To directly address the effect of CuE on autophagosome
formation, we then tested its effect on the accumulation of
vesicles positive for the specific autophagosomal marker LC3
[58, 59]. Upon induction of autophagy, LC3 becomes lipi-
dated, associates with a nascent autophagosomes, and stays
associatedwith the autophagosomeuntil it is degradedwithin
a lysosome. Therefore, we stained neuronal PC12 cells for
LC3 and determined the presence of LC3-positive autophagic
vacuoles by immunofluorescence (Figures 8(a) and 8(b)). On
its own,CuE treatment decreased the number of LC3-positive
autophagosomes, suggesting that CuE inhibits autophagy
(Figure 8(b)). Importantly, inhibition of lysosomal activity
with bafilomycin to prevent degradation of the autophago-
somes failed to rescue LC3-positive vesicles in CuE-treated
cells. These results suggest that the decrease in autophago-
somes observed in CuE-treated cells is the consequence of
reduced autophagy rather than an increase in autophagic
flux. To further demonstrate that CuE decreases autophagy,
we measured the expression of the autophagy substrate p62
by western blotting (Figure 9). Consistent with an inhibitory
effect on autophagy, CuE caused the accumulation of p62
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Figure 8: (a) Immunofluorescence detection of LC3b in neuronal PC12 cells. Punctate structures stained for LC3b represent specific
autophagic vacuoles. Scale bar = 50 𝜇m. (b)Histogram.CuE treatment did not increase the total number of LC3b-positive autophagosomes but
rather slightly decreased their presence. Bafilomycin (Baf), an inducer of autophagy, was used as a positive control. CuE treatment before Baf
(Baf + CuE) administration clearly reduced the Baf-induced formation of LC3b-positive autophagosomes. Data are expressed as percentage
of cellular surface occupied by LC3b vacuoles (area fraction) and aremeans ± S.E.M. 𝑛 = 3. ∗∗∗𝑃 < 0.001 and ∗𝑃 < 0.05 versus Ctrl. ◊𝑃 < 0.05
versus Baf.
in neuronal cells. As with LC3-positive autophagosomes,
inhibition of lysosomal acidification with bafilomycin (Baf,
Figure 9) increased p62 levels in control cell but did not
further increase them in CuE-treated cells. Altogether, our
results indicate that CuE decreases autophagic flux.
3.4. CuE Reverts Abnormal Relocalization of Lysosomes
Induced by MPP+ Treatment. We then tested the effect of
CuE on the subcellular distribution of lysosomes and mito-
chondria.These organelles were visualised using an antibody
against the lysosomal membrane protein LAMP2a or against
the mitochondrial matrix protein mtHSP70 (Figure 10).
MPP+ treatment resulted in a strong clustering of lysosomes
(green) in the perinuclear region of the cells (Figure 10,
MPP+, arrowheads). Figure 10 shows mitochondria stained
with mtHSP70 in red (second line) and also illustrates that
mitochondria are pushed away from the perinuclear region
by lysosomal clusters (Figure 10, merge and zoom 2x). While
CuE failed to rescue the number of acridine orange acidic
vesicles, in MPP+-treated cells (Figure 6), it reversed lysoso-
mal clustering as illustrated in Figure 10 (CuE +MPP+, zoom
2x) and increased the number of large Cyto-ID-positive vesi-
cles (Figure 7, histogram). These results indicate that while
CuE does not directly promote lysosomal acidification, itmay
regulate the formation of other types of autophagolysosomal
vesicles that correlate with improved survival.
3.5. CuE Does Not Visibly Alter the Neuronal Cytoskeleton.
Since autophagy requires the presence of an intact cytoskele-
ton [67], we analysed the effect of CuE on neuronal PC12 cell
cytoskeleton. As shown in Figure 11, CuE did not visibly affect
the actin cytoskeleton, suggesting that the accumulation of
autophagic vacuole is not the consequence of an altered actin
cytoskeleton (Figure 11, red staining). As organellemovement
normally depends on microtubules, we also analysed the
influence of CuE on 𝛽3-tubulin staining. As with actin, a 24 h
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Figure 9: p62 protein expression as revealed by western blot. CuE
significantly increases p62 expression, a cargo protein involved in
autophagic flux, Baf induces a strong expression of p62, and the
administration of CuE + Baf does not additionally increase p62
protein expression. TH was used to normalise p62. Values are the
average of 3 samples from 3 independent experiments for a total
of 9 measurements. Data are expressed as means ± S.E.M. 𝑛 = 3.
∗∗∗
𝑃 < 0.001 and ∗𝑃 < 0.05 versus Ctrl.
treatment with 10−10MCuEdid not visibly altermicrotubules
(Figure 11, green staining), nor intermediate filaments NF-
M (purple staining), indicating that, at the concentration
used, CuE does not affect the cellular cytoskeleton in our
postmitotic cellular paradigm.
4. Discussion
This study details for the first time the neuroprotective effects
of CuE, a molecule from the cucurbitacin family. Cucur-
bitacins, phytosterols foundmostly in cucurbits, are currently
studied for their important anticancer potential [41, 43, 68,
69]. Some of these compounds also possess interesting anti-
inflammatory and antioxidant properties in mitotic cell lines
[70, 71]. CuE, in particular, has been proven to impact
signal transduction and activation of transcription-3 (STAT3)
effect [40] and show an important actin-binding activity that
stabilizes microfilaments [42]. This leads to cell cycle arrest
and apoptosis in rapidly dividing cells, such as tumor cells
[37]. Besides, CuE has been reported to suppress cell invasion
and metastasis [68] and does not affect apoptosis in human
lymphocytes as compared to prostate adenoma and breast
cancer cell lines [70].
Polyphenols and phytosterols have been widely studied
for their neuroprotective properties often mediated by their
antioxidant activity [29, 55, 72]. A variety of molecules such
as resveratrol, quercetin, and sesamin also exert antiapoptotic
and anti-inflammatory roles in nonmitotic cells, as demon-
strated by others and our previous work [47, 48, 73–75]. Alto-
gether their prosurvival activities on neuronal degeneration
might contribute to the developing of new avenues for com-
plementing current therapies for neurodegenerative diseases.
To our knowledge, CuE has never been used in a neurodegen-
eration model of postmitotic neuronal cells and our results
are the first to endorse its neuroprotective properties and pro-
pose original mechanisms for its activity, such as the modu-
lation of cellular macroautophagy.
We performed our experiment in postmitotic DAergic
neurons, NGF-differentiated PC12 cells. This cellular para-
digm has been extensively used by us and others to demon-
strate that several polyphenols and lignans are indeed neuro-
protective by reducing apoptosis and oxidative stress [48, 55,
76–80]. After NGF administration, PC12 cells adopt a neu-
ronal-like phenotype asmanifested by secretion of high levels
of dopamine and the expression of TH, DAT, neurofilaments,
and estrogen receptor-alpha and estrogen receptor-beta [28,
81–83].
Abundant literature reports CuE cytotoxic effects on
tumor cells lines leading to cell-arrest [37, 40, 42]. In our
postmitoticmodel, directly administrating CuE at a low dose,
(10−10M) to the culture medium of neuronal cells, revealed
important neuroprotective properties, as demonstrated by
CuE’s ability to prevent MPP+-induced cell death. This is not
the first time that phytochemicals show apparent paradoxical
effects [47, 76]. It is reasonable to speculate that low doses of
CuEmay be involved in activating adaptive responses in post-
mitotic cellular model. Literature reports prosurvival antiox-
idant properties of polyphenols and phytosterols. Following
this line of evidence, we performed oxidative stress assays in
our DAergic cellular model to help pinpoint the mechanism
of CuE-mediated neuroprotection. In our cellular paradigm,
10−10M CuE did not possess any significant antioxidant
effect, as shown by both DHR oxidization assay and superox-
ide anion fluorescence (MitoSox assay). A similar intriguing
result has been recently reported with cucurbitacin B and
cucurbitacin I in a tumor model, linking ROS production
with autophagy induction in cucurbitacin-treated cells [84].
As autophagy impairment is observed in several syn-
dromes of neurodegeneration such as PD [9, 85, 86], the
autophagy-lysosome pathway has been proposed as a target
for neurodegeneration therapies [11, 20, 87]. On the other
hand, autophagy activation has been shown to be detrimental
in other models of neuronal loss such as following a stroke
[88, 89]. Therefore, while autophagy activation can promote
survival when the accumulation of damaged cellular com-
ponents is the primary issue, it can also have detrimental
consequences for neurons.
In this context, it is noteworthy that the neuroprotective
effects of CuE in a neuronal model of MPP+-induced cell
death are associated with a decrease in autophagy. In fact,
both the decrease in LC3-positive autophagosomes and the
accumulation of p62 are consistent with a decrease in auto-
phagy initiation and possibly impaired lysosomal degrada-
tion of autophagosomes. This is suggested by the observa-
tion that bafilomycin failed to recover LC3 vesicles or p62
protein expression. On the other hand, CuE increased the
presence of large autophagic vacuoles (>1 𝜇m) and rescued
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Figure 10: Immunofluorescence pictures illustrating lysosome and mitochondria localization. Neuronal cells were double-stained for
LAMP2a, a specific lysosomal marker (green fluorescence), and mtHSP70, a specific mitochondrial marker (red fluorescence). MPP+
condition shows delocalisation of lysosomes (green staining and arrowheads) in dense clusters near the nuclei, resulting in a staining
pattern dramatically different from the other conditions. Administration of CuE appears to rescue in part normal lysosome localization.
Microphotographs are representative of 3 different experiments. Scale bar = 10𝜇m.
lysosomal distribution in MPP+-treated cells, suggesting that
the decrease in lysosomal delivery of autophagosomes caused
by CuE could rescue some aspects of lysosomal function. As
lysosomes play an important role in neurons [90], this could
explain, at least in part, the neuroprotective role of CuE.
In dynamicmitotic cell lines, such as tumor cells, CuE has
been reported to promote the remodeling of actin filaments
leading to the formation of actin clusters [42, 44]. However,
we did not detect any changes in the appearance of the actin
cytoskeleton in our paradigm following CuE administration.
It is however difficult to conclude that CuE does not alter
the cellular cytoskeleton since other studies reporting CuE-
induced cytoskeletal changes have used higher doses of CuE
in different cellular system [42, 44]. Thus, we cannot exclude
the possibility that CuE affects the cytoskeleton in a more
subtle manner in our system. In addition, MPP+ may impair
microtubules dynamics, as recently reported in [91, 92]. Our
results do not exclude the possibility that the neuroprotective
effects of CuE may be related to a stabilizing action exerted
on the neuronal cytoskeleton.
In conclusion, autophagy regulation as a means of neuro-
protection is rather promising, though it is important to
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consider its “ying-yang” role. Indeed, asmuch as the recycling
of toxic organelles and proteins might benefit cell, too much
autophagy may also result in autophagic cell death [93, 94].
Therefore, the use of molecules targeting the autophagic
pathways will require important fine-tuning of dosages. Our
data revealing a modulation of the autophagy pathways
when using low doses of CuE and a particular role on
lysosomal function propose that this terpenoid molecule
could have powerful roles in the cellular dynamic underlying
neurodegeneration and neuroprotection.
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